{
  "page_summary": "This page discusses factors involved in breast cancer disease management, including tumor characteristics, lymph node status, receptor status, metastatic status, genetic mutations, and patient factors. It describes treatment categories based on intent (curative or palliative) and setting (neoadjuvant, adjuvant, advanced/metastatic), emphasizing how treatment intent/setting can influence trial design. The page does not provide details about specific clinical trial endpoints.",
  "endpoint_candidates": []
}